Format

Send to

Choose Destination
Ann Oncol. 2012 Jul;23(7):1788-95. doi: 10.1093/annonc/mdr484. Epub 2011 Nov 5.

Trastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell lines.

Author information

1
Molecular Therapeutics for Cancer Ireland (MTCI), National Institute for Cellular Biotechnology (NICB), Dublin City University, and Department of Pathology and Laboratory Medicine, St. Vincent's University Hospital, Dublin, Ireland. denis.collins@dcu.ie

Erratum in

  • Ann Oncol. 2013 Jan;24(1):268.

Abstract

BACKGROUND:

Antibody-dependent cell-mediated cytotoxicity (ADCC) mediated by CD56+natural killer (NK) cells may contribute to the activity of trastuzumab in HER-2-amplified tumours. In this study, we investigated the possibility that trastuzumab might induce ADCC against HER-2-non-amplified breast cancer cells.

METHODS:

Induction of NK cell-mediated ADCC was examined in trastuzumab-treated HER-2-non-amplified breast cancer cell lines. HER-2 protein levels were also determined in tumour and autologous normal tissue samples from patients with HER-2 negative breast cancer.

RESULTS:

Trastuzumab induced a significant ADCC response in the HER-2-amplified HCC1954 and SKBR3 cell lines, and in all five of the non-amplified cell lines, which had low levels of detectable HER-2 by western blot (CAL-51, CAMA-1, MCF-7, T47D, and EFM19). Trastuzumab did not induce ADCC in the K562 control cell line or MDA-MB-468, which has very low levels of HER-2 detectable by enzyme-linked immunosorbent assay (ELISA) only. HER-2 protein was detected by ELISA in 14/15 patient tumour samples classified as HER-2-non-amplified. Significantly lower levels of HER-2 were detected in normal autologous tissue compared with tumour samples from the same patients.

CONCLUSION:

Our results suggest that HER-2-non-amplified breast cancer cells, with low but detectable levels of HER-2 protein, can bind trastuzumab and initiate ADCC.

PMID:
22056974
DOI:
10.1093/annonc/mdr484
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center